Iryo Crypto Coin Rank 4000
Website White Paper
Buy / Sell
price in US dollars is currently
, and if converted to Bitcoin
. A total of 0 coin's
are currently circulating in the Market. Iryo
prices are currently experiencing a change of 0 %
, check all cryptocurrency.
Over the past 24 hours 0.000 M US dollars Iryo
has been traded on Crypto Exchanges
. Get Iryo's progress by adding it to your favourites
and creating a free portfolio
if you wish.
Iryo ICO Details
Security Audit Company
ICO Legal Form
Iryo’s is an open-source platform designed to drive a new generation of highly effective data exchange within the medical community. Unified records will allow individuals to manage and monetize their medical data by opening it up to research. Bearer health records will become the new standard, allowing patients to fully own and leverage their sensitive data through the use of their private keys. Bearer instruments shift the balance of power from the institution to the patient.
Iryo Network participants will need to stake a predefined number of IRYO tokens to be able to interact within the network. Staking ensures all network participants remain accountable and keeps the entire medical network operating smoothly.
- Vasja Bočko: CEO.
- Dominik Žnidar: CTO.
- Peter Kuralt: Head of Strategic Development.
- Andrej Mihelič: UX/UI Designer.
The Iryo ICO will begin on TBA. The ICO token supply represents 80% of the total token supply, so there is a total of 240,000,000 IRYO tokens available (including Pre-ICO), for 0.11 USD. The ICO funding target is 8,000,000 USD, the funding cap is 26,000,000 USD and is expected to end on TBA or when the funding cap is reached.
Token Reserve Split (20%):
- 10% Team + Iryo;
- 5% Private Sale;
- 5% Airdrops.
The Iryo ICO features the following bonus structure.
- 20% Early Birdy Whitelisting Bonus;
- 20% Bonus (March 29th - April 6th);
- 10% Bonus (April 7th - April 13th).
Read the Disclaimer
: All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer